Literature DB >> 9299358

Altered expression of troponin T isoforms in mild left ventricular hypertrophy in the rabbit.

Z Chen1, A Higashiyama, H Yaku, S Bell, J Fabian, M W Watkins, D J Schneider, D W Maughan, M M LeWinter.   

Abstract

Alterations in troponin T (TnT) isoforms have been reported in severe human and experimental heart failure (HF), and may play a role in the depressed myofibrillar ATPase activity observed in this condition. It is unclear whether these alterations reflect very severe hemodynamic derangement or are a component of mild hypertrophic stress. Therefore, we studied the expression of TnT isoforms (SDS-PAGE, Western blots), myosin isoforms, myofibrillar ATPase activity, and left ventricular (LV) mechanoenergetics (rbc perfused, isovolumically contracting isolated heart) in a rabbit model of mild hypertrophy (LVH) due to gradual hypertension caused by 12 weeks of cellophane wrap of the kidneys (n=12). LV/body weight ratio increased by 28% in LVH compared to shams (P<0.001); no animals had evidence of HF. In LVH, the percentage of TnT2 was modestly but significantly increased compared to shams [6.2+/-1.9 (+/-S.D. ) v 3.7+/-1.0%, P<0.05], mainly as a consequence of a parallel decrease in TnT4 (P=0.07). Sham hearts ranged from 75-100% V3 isomyosin, whereas all LVH hearts had 100% of the V3 form. There were no significant differences in myofibrillar ATPase activity or mechanical variables, including contraction and relaxation rates. The slope of the VO2-pressure-volume-area relation (a measure of the energy conversion efficiency of the contractile machinery) was also unchanged. We conclude that in the rabbit, shifts in TnT isoforms toward a more "fetal" pattern occur during mild LVH and, therefore, are likely to be a general feature of the response to hemodynamic stress, rather than a phenomenon confined to end-stage disease. These modest shifts are not associated with major alterations in LV myofibrillar ATPase activity or mechanoenergetics. Copyright 1997 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299358     DOI: 10.1006/jmcc.1997.0468

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  8 in total

Review 1.  Molecular and cellular mechanisms of myocardial remodeling.

Authors:  Melanie Maytin; Wilson S Colucci
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

Review 2.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 3.  Functional consequences of sarcomeric protein abnormalities in failing myocardium.

Authors:  Martin M LeWinter
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

Review 4.  Mechanical Regulation of Cardiac Aging in Model Systems.

Authors:  Ayla O Sessions; Adam J Engler
Journal:  Circ Res       Date:  2016-05-13       Impact factor: 17.367

Review 5.  Sarcomeric protein isoform transitions in cardiac muscle: a journey to heart failure.

Authors:  Zhiyong Yin; Jun Ren; Wei Guo
Journal:  Biochim Biophys Acta       Date:  2014-11-08

6.  Predicting cardiomyopathic phenotypes by altering Ca2+ affinity of cardiac troponin C.

Authors:  Michelle S Parvatiyar; Jose Renato Pinto; Jingsheng Liang; James D Potter
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

Review 7.  Thin filament remodeling in failing myocardium.

Authors:  Peter VanBuren; Yoko Okada
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.654

Review 8.  Gene regulation, alternative splicing, and posttranslational modification of troponin subunits in cardiac development and adaptation: a focused review.

Authors:  Juan-Juan Sheng; Jian-Ping Jin
Journal:  Front Physiol       Date:  2014-04-30       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.